Graph RAG represents a shift from text-centric retrieval to structure-aware understanding to enable: 1. More consistent answers 2. Better global context 3. Reduced hallucination 4. Stronger reasoning over relationships Rather than asking LLMs to guess structure from text at generation time, Graph RAG makes structure explicit upfront.

Apotek Genesis "Antibody Redesign" is a platform-based antibody optimization solution that enables rapid exploration of CDR sequence space, structural prediction, and binding affinity ranking—accelerating the path from lead antibody to optimized therapeutic candidate.

"Machine-learning Method on Vectorized Three-Dimensional Model and Learning System Thereof" describes a novel method for utilizing vectorized 3D models to generate synthetic data of real-world objects for AI training. It can be applied for various applications, including object identification and anomaly detection, where training data are difficult or economically infeasible to acquire, and the robotic agents need these capabilities to function and swiftly interact with the p

Retrospective Probability of Success (PoS) answers “what usually happens across programs.” Apotek Signal answers “what is likely to happen for this asset.” Key Takeaways Apotek Signal quantifies clinical risk at the asset level :  It estimates the probability that a specific trio of drug–target–indication will succeed at a given clinical phase. Phase-aware by design : Separate models for clinical trial phase I, II, and III reflect how decision criteria change across developme

Marketing measurement has gone through three distinct phases: 1. Legacy MMM Era (pre-2010s) 2. Attribution Boom (2010s) 3. MMM Rebirth (2020s) This isn’t a story about preference. It’s a story about adaptation to thrive in the everchanging business world.

How optimizing leads early can foresee risks, ensure safety and developability, and protect intellectual properties

Data Detail is Crucial: To perform causal analytics like Marketing Mix Modeling, you must preserve raw, event-level data (joint distributions). Summary reports (marginals) discard the necessary context to attribute success to specific combinations of customer traits. Avoid the "Average" Trap: Aggregated data can hide the true story. Two completely different customer behaviors can look identical in summary reports, making accurate attribution impossible without the raw source

Marketers have more performance data than ever, yet trust in that data isn’t really improving. The fix lies in performance measurement using Marketing Mix Modeling.

Translating AI-powered research into real-world cancer impact Apotek Joins NSF I-Corps Spark Special Cohort on AI/ML and Cancer Care Taipei | [November 12, 2025] — Vizuro is proud to announce that our Apotek platform  has been selected for the National Science Foundation (NSF) I-Corps Spark Cohort , beginning November 13, 2025 . This specialized program focuses on AI/ML-powered innovations in cancer research and care , empowering teams to translate cutting-edge science into

In the highly regulated and patient-centric world of pharmaceutical launches, gaining a rapid, nuanced understanding of public perception is no longer optional—it is a critical necessity. Social listening has evolved from a simple monitoring tool into a sophisticated intelligence engine, providing real-time data that directly informs safety monitoring, brand strategy, and commercial success.

Partnership with Professor Woei-Jer Chuang of NCKU to explore AI-powered discovery in protein drug design Vizuro Apotek AI Drug Discovery Platform x Industry-Academia Collaboration with NCKU Taipei | [October 27, 2025] — Vizuro LLC, a leading innovator in multimodal causal AI and generative AI for drug discovery, today announced the signing of a Memorandum of Understanding (MOU) with Professor Woei-Jer Chuang, Ph.D., of the Department of Biochemistry and Molecular Biology, Na

AI is redefining finance, but trust remains its currency. As AI systems make increasingly high-stakes decisions—who gets a loan, who’s flagged for AML, who receives an offer—the cost of error multiplies. The message for financial leaders is clear: A black-box AI might optimize for accuracy but can expose the bank to unseen bias, regulatory penalties, or wasted budgets. A Responsible AI framework builds resilience, customer confidence, and long-term value.

Going beyond correlation to causality can reveal tremendous value and insights Key Takeaway Drug discovery has entered the era of big data. Every year, thousands of disease and normal samples are profiled — yet one critical bottleneck remains: identifying clinically meaningful target–marker gene pairs for new drug development . The core value of Apotek Path is for this purpose: Identify disease-relevant targets → Causal modeling reveals mechanistic gene interactions tailore

The future of Physical AI isn't just about better technology—it's about smarter SDG implementation. Organizations that understand how to match SDG strategies with their specific Physical AI needs will gain significant competitive advantages.

Why causal AI is becoming pharma’s next strategic differentiator — from target validation to clinical trials and real-world evidence. Visualizing the Ladder of Causation in Pharma: from seeing correlations, to doing interventions, to imagining counterfactuals — the foundation of causal AI in drug discovery. Introduction: The Limits of Correlation in Drug Discovery Drug discovery today generates unprecedented volumes of data. Omics, imaging, electronic health records, and real

How Corvus's synthetic data generation platform addresses the critical challenge of matching model capabilities with data requirements...

Ad platform reports from Google, Meta, and others usually over-credit the last click and don’t reveal the true drivers of ROI....

Transforming Industrial Inspection with Corvus For industrial manufacturers, the promise of AI for quality control is undeniable....

Partnership with Professor Tsong-Long Hwang of CGUST to explore AI-powered innovations in small molecule drug design Vizuro Apotek AI Drug Discovery Platform x Industry-Academia Collaboration with CGUST Taipei | [August 22, 2025] — Vizuro LLC, a leading innovator in multimodal causal AI  and generative AI  technology, announced today that it has signed a Memorandum of Understanding (MOU) with Tsong-Long Hwang, Ph.D., Vice President and Distinguished Professor at Chang Gung U

Key Takeaways Synthetic data generation has evolved from a niche research topic to an essential technology for AI development. The...